MENU
ANIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Anixa Biosciences (ANIX) Ownership - Who owns Anixa Biosciences?
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology... Show more
Industry: #Computer Peripherals
Profile
Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
87.58M
P/E Ratio
N/A
Total Cash
17.26M
Projected Growth
N/A
Total Debt
230K
Revenue
N/A
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash/Share
0.54
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANIX
Capitalization
87.6M
P/E Ratio
N/A
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash
17.3M
Total Cash/Share
0.54
Total Debt
230K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
17.9M
P/B Ratio
4.91
Cash Flow
N/A
Earnings
-0.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
322K
Current Ratio
9.35
Current Revenue Per Employee
42000.00
Dividends Per Share - Security
N/A
EBITDA
-13.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
23.33
Revenue To Assets
-56.38
Shares Held By Institutions
18.4M
Shares Outstanding - Current
32.2M
Total Liabilities
2.19M
Total Volume MTD
N/A
Value
-1
Gain YTD
17.672
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of non-invasive blood tests for the early detection of solid tumor based cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com